EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments

Shuhei Tokiwa, Keisuke Natsume, Akira Yoshida, Hajime Yonezawa, Kentaro Kawamura, Kazuki Nakanishi, Nayuta Higa, Ryosuke Hanaya, Megumi Shimodozono

Journal of Neuro-Oncology · 2026

DOI: 10.1007/s11060-026-05784-0 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Neuro-Oncology, 2026. Verfasst von Shuhei Tokiwa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Kagoshima University Hospital, Kagoshima, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Walking, Patient Discharge. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kagoshima University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Walking ability is readily assessed at the bedside; however, whether it adds prognostic information beyond global performance status in glioblastoma (GBM) is unknown. We examined the Functional Ambulation Category (FAC) at six peri-treatment time points and whether discharge FAC is associated with overall survival (OS) independently of contemporaneous performance status.

Methods

This retrospective single-center study included 185 adults with newly diagnosed GBM treated from 2011 to 2020. FAC was assessed preoperatively, on postoperative day 5, before chemoradiotherapy, at discharge, and 1 and 4 months after discharge. The primary analysis used a discharge landmark, with FAC grouped as 0–1, 2–4, and 5 and adjustment for age, sex, extent of resection, and discharge Karnofsky Performance Status (KPS). Incremental performance was assessed using Akaike information criterion (AIC) and Harrell’s C-index.

Results

Higher FAC was associated with longer OS at all six time points, with the strongest univariable association at discharge. In the discharge-landmark model ( n = 162; 138 deaths), adjusted hazard ratios versus FAC 0–1 were 0.45 (95% CI, 0.27–0.73) for FAC 2–4 and 0.33 (95% CI, 0.17–0.63) for FAC 5. Adding FAC improved fit and discrimination (ΔAIC, − 8.4; ΔC-index, + 0.022; p = 0.002). Estimates were unchanged after additional adjustment for bevacizumab and post-discharge temozolomide.

Conclusion

Discharge FAC carries prognostic information not captured by contemporaneous global performance status and is a practical bedside marker at the transition to post-discharge care, rather than a stand-alone prediction tool. Registration This study was not prospectively registered. Protocol No prospective study protocol was prepared.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsWalkingPatient DischargeHumansFemaleRetrospective StudiesPrognosisMaleMiddle AgedAgedFollow-Up StudiesSurvival RateAdultKarnofsky Performance Status

Stichwörter der Autor:innen

ChemoradiotherapyFunctional ambulation categoryGlioblastomaPrognosisRehabilitation

Autor:innen und Institutionen

  • Department of Rehabilitation, Kagoshima University Hospital, Kagoshima, Japan.
  • Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1, Sakuragaoka, Kagoshima, 890-8520, Japan.
  • Department of Rehabilitation, Kagoshima University Hospital, Kagoshima, Japan. akiray@m.kufm.kagoshima-u.ac.jp.
  • Department of Rehabilitation and Physical Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1, Sakuragaoka, Kagoshima, 890-8520, Japan. akiray@m.kufm.kagoshima-u.ac.jp.
  • Department of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Department of Physical Therapy, School of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.

Förderung

  • Kagoshima University

Zitieren

APA

Tokiwa, S., Natsume, K., Yoshida, A., Yonezawa, H., Kawamura, K., Nakanishi, K., Higa, N., Hanaya, R., & Shimodozono, M. (2026). Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-026-05784-0

Vancouver

Tokiwa S, Natsume K, Yoshida A, Yonezawa H, Kawamura K, Nakanishi K, et al. Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments. Journal of Neuro-Oncology. 2026. doi:10.1007/s11060-026-05784-0

BibTeX
@article{Tokiwa2026,
  author = {Tokiwa, Shuhei and Natsume, Keisuke and Yoshida, Akira and Yonezawa, Hajime and Kawamura, Kentaro and Nakanishi, Kazuki and Higa, Nayuta and Hanaya, Ryosuke and Shimodozono, Megumi},
  title = {Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  doi = {10.1007/s11060-026-05784-0}
}
Kostenlos starten →